Kirsten rat sarcoma oncogene test market
Disease awareness boosts Japan’s KRAS oncogene test market
Disease awareness boosts Japan’s KRAS oncogene test market
Nucleic acid amplification tests dominate the market.
Join the community
Most Read
1. How fast can India’s healthcare scale with private equity? 2. Global diagnostic lab market poised to hit $223b 3. Contact lens and solutions market on track to reach $38b by 2032 4. Kearney’s Dr Stephanie Allen: Health systems must pivot toward longevity and lifelong health 5. Asian Hospital launches Philippines’ first specialised hernia centreResource Center
Events
Partner Events
Event News
Co-Written / Partner
EY-Parthenon’s Abhay Bangi: Healthcare sector moving into more experiential, regionally mobile future
He explores how healthcare in Asia is evolving and how organisations can manage innovation, regulation, expansion, and future challenges.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation